IDDA 2023 brings together members of the inhaled drug development and research industry, including those working in research and development, quality monitoring and production enterprises, universities, colleges and other groups of professionals in the fields related to inhaled drug research, development, production, quality and application.
IDDA provides a platform for sharing of knowledge between industry insiders and at the same time enable interactive communication on academic views, technical applications, laws and regulations, product trends, clinical research, clinical applications, and market analysis in the field. IDDA aims to promote the development of China’s inhalation drug industry, and to improve domestic inhaled drug research and development, product technical standards and clinical applications.
Representatives from Copley will be available throughout the event. To arrange a meeting, please contact us at chinasales@copleyscientific.com.
